Asahi Intecc
Asahi Intecc is a Japanese company established in 1976, developing and supplying high-quality medical products for catheter treatment (guide wires, guiding catheters and balloon catheters) using an integrated in-house production system. Asahi Intecc's leading products are currently for the cardiovascular system area, but treatment areas are expanding to encompass other areas such as peripheral vascular (lower-limb), abdominal and cardiovascular areas.
Kimal
Kimal is an innovative manufacturer of customised procedure packs and vascular access devices to clinical departments in over 70 countries worldwide. The Company manufactures over 2 million procedure packs and vascular access devices every year for a range of specialities including: cardiology, radiology, pacing, laparoscopy, and cardiac surgery; and our unique, ground-breaking central venous catheter technology is helping to reduce patient risk in hospitals across the world.
Microvention
MicroVention is a rapidly growing medical device company that has pioneered the development of catheter-based, minimally invasive, neuroendovascular technologies that provide therapeutic advantages for neurovascular disorders. Since the launch of their First Generation HydroCoil™ embolic system in 2003, MicroVention has expanded its portfolio to every corner of the neuroendovascular industry—now producing Best-in-Class Embolic Coils, Intrasaccular Devices, Coil-Assist Stents, and Flow Diverters. With the celebration of their 3rd FDA Premarket Approval (PMA) in an 18-month timeframe, MicroVention now holds more PMA’s than any other company in their industry as of January 2020.
LSO Medical
Founded in 2002, LSO Medical is a French company based in Loos, a pioneer and expert in thermal endovenous treatment. With more than 20 years of experience, LSO Medical is a key player in the design, production and marketing of medical lasers
Microport
MicroPort® is a premier global medical solutions provider, pushing boundaries so patients everywhere can enjoy better and longer lives. During the past two decades, we have worked to accelerate innovation and broaden access to technologies across multiple therapeutic fields, including orthopedics, cardiovascular intervention, cardiac rhythm management, electrophysiology, among others. We currently have over 300 approved products used in more than 10,000 hospitals worldwide. In fact, every 6 seconds a patient benefits from a MicroPort® life-changing solution. Founded in 1998, as a company dedicated to making emerging minimally invasive technologies more accessible to more patients across the world. Today, MicroPort® is a leading provider of cardiovascular therapeutic solutions.
Terumo Aortic
Terumo Aortic has emerged from the recent integration of Bolton Medical and Vascutek by Terumo Corporation, launching the most comprehensive portfolio of products in the aortic space. By committing to delivering solutions that address every segment of the aorta, we have set ourselves apart. We are 100% focused on the aorta, from the aortic root to the iliacs, and provide a range of off-the-shelf products and individualised solutions to suit varying patient anatomy. Whether you are looking for an endovascular, surgical or hybrid* approach, we are ready to accept your unique challenge and exceed your expectations.
Eclipse Medical
Eclipse Medical is a Structural Heart Company focused on developing the Omega LAA Occluder
Inari
Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases.
iVascular
The purpose of IVascular is to develop innovative advanced medical devices and therapies for the treatment of disorders of the cardiovascular system.
Products + Features
P+F Products + Features GmbH is a medical technology company focused on research, development, and manufacture of innovative minimally invasive solutions in the field of cardiology. Having more than 25 years of experience in the medical field, the leadership team of P+F has built up a complete infrastructure for research, development, manufacture, and distribution in order to deliver significant innovations and add economic value to its customers.
Worldwide Innovations & Technologies, Inc. / RADPAD
Worldwide Innovations & Technologies, Inc. (WIT), headquartered in Kansas City, was founded in July, 1992 with the purpose of developing and marketing radiation protection products. RADPAD® emerged from WIT’s developmental years. RADPAD® products are lead free and can be sterilized as necessary. They are completely disposable and create no environmental issues. Further, the RADPAD products allow medical facilities to comply with the ALARA (As Low As Reasonably Achievable) standard of the radiation protection industry.
Biolife LLC
Biolife, LLC is a privately-held medical device company that manufactures and distributes breakthrough, non-prescription products that stop bleeding and seal access sites. The products are used in hospitals, first aid kits for the workplace, by athletic trainers in sports, and by consumers for home use. In hospitals, StatSeal products are used to seal vascular access sites, prevent unnecessary dressing changes and improve patient outcomes. For First Aid applications at home, at work or in sports, the WoundSeal products form an instant scab that stops bleeding and seals/protects the wound
Philips
Royal Philips of the Netherlands is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.
AngioDynamics
AngioDynamics Inc designs, manufactures and sells medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings.